Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1995 Mar;4(2):149–156. doi: 10.1155/S0962935195000263

Influence of sensitization and allergen provocation procedures on the development of allergen-induced bronchial hyperreactivity in conscious, unrestrained guinea-pigs

R E Santing 1,✉, C G Olymulder 1, B van Diepen 1, H Meurs 1, J Zaagsma 1
PMCID: PMC2365622  PMID: 18475633

Abstract

The effects of different sensitization and allergen provocation regimens on the development of allergen-induced bronchial hyperreactivity (BHR) to histamine were investigated in conscious, unrestrained guinea-pigs. Similar early and late phase asthmatic reactions, BHR for inhaled histamine after the early (6 h) as well as after the late reaction (24 h), and airway inflammation were observed after a single allergen provocation in animals sensitized to produce mainly IgG or IgE antibodies, respectively. Repeating the allergen provocation in the IgE-sensitized animals after 7 days, using identical provocation conditions, resulted in a similar development of BHR to histamine inhalation. Repetition of the allergen provocation during 4 subsequent days resulted in a decreased development of BHR after each provocation, despite a significant increase in the allergen provocation dose necessary to obtain similar airway obstruction. The number of inflammatory cells in the bronchoalveolar lavage was not significantly changed after repeated provocation, when compared with a single allergen provocation. Finally, we investigated allergen-induced bronchial hyperreactivity by repetition of the sensitization procedure at day 7 and 14 (booster), followed by repeated allergen provocation twice a week for 5 weeks. Surprisingly, no BHR to histamine could be observed after either provocation, while the number of inflammatory cells in the bronchoalveolar lavage fluid after 5 weeks was enhanced compared with controls. These data indicate that both IgE and IgG sensitized guinea-pigs may develop bronchial hyperreactivity after a single allergen provocation. Repeated allergen exposure of IgE sensitized animals causes a gradual fading of the induced hyperreactivity despite the on-going presence of inflammatory cells in the airways, indicating a mechanism of reduced cellular activation.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Bijlsma J. W., Van den Brink H. R. Estrogens and rheumatoid arthritis. Am J Reprod Immunol. 1992 Oct-Dec;28(3-4):231–234. doi: 10.1111/j.1600-0897.1992.tb00800.x. [DOI] [PubMed] [Google Scholar]
  3. Bizzarro A., Valentini G., Di Martino G., DaPonte A., De Bellis A., Iacono G. Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome. J Clin Endocrinol Metab. 1987 Jan;64(1):32–36. doi: 10.1210/jcem-64-1-32. [DOI] [PubMed] [Google Scholar]
  4. Carruba G., Leake R. E., Rinaldi F., Chalmers D., Comito L., Sorci C., Pavone-Macaluso M., Castagnetta L. A. Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells. Steroids. 1994 Jul;59(7):412–420. doi: 10.1016/0039-128x(94)90010-8. [DOI] [PubMed] [Google Scholar]
  5. Castagnetta L. A., Granata O. M., Lo Casto M., Calabró M., Arcuri F., Carruba G. Simple approach to measure metabolic pathways of steroids in living cells. J Chromatogr. 1991 Dec 6;572(1-2):25–39. doi: 10.1016/0378-4347(91)80470-w. [DOI] [PubMed] [Google Scholar]
  6. Castagnetta L., Granata O. M., Polito L., Blasi L., Cannella S., Carruba G. Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and -response of human prostate cancer cells. J Steroid Biochem Mol Biol. 1994 Jun;49(4-6):351–357. doi: 10.1016/0960-0760(94)90279-8. [DOI] [PubMed] [Google Scholar]
  7. Chang C. S., Whelan C. T., Popovich T. C., Kokontis J., Liao S. T. Fusion proteins containing androgen receptor sequences and their use in the production of poly- and monoclonal anti-androgen receptor antibodies. Endocrinology. 1989 Aug;125(2):1097–1099. doi: 10.1210/endo-125-2-1097. [DOI] [PubMed] [Google Scholar]
  8. Cohen J. H., Danel L., Cordier G., Saez S., Revillard J. P. Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J Immunol. 1983 Dec;131(6):2767–2771. [PubMed] [Google Scholar]
  9. Crawford D., Cowan S., Hyder S., McMenamin M., Smith D., Leake R. New storage procedure for human tumor biopsies prior to estrogen receptor measurement. Cancer Res. 1984 Jun;44(6):2348–2351. [PubMed] [Google Scholar]
  10. Cutolo M., Accardo S. Sex hormones, HLA and rheumatoid arthritis. Clin Exp Rheumatol. 1991 Nov-Dec;9(6):641–646. [PubMed] [Google Scholar]
  11. Cutolo M., Accardo S., Villaggio B., Clerico P., Bagnasco M., Coviello D. A., Carruba G., lo Casto M., Castagnetta L. Presence of estrogen-binding sites on macrophage-like synoviocytes and CD8+, CD29+, CD45RO+ T lymphocytes in normal and rheumatoid synovium. Arthritis Rheum. 1993 Aug;36(8):1087–1097. doi: 10.1002/art.1780360809. [DOI] [PubMed] [Google Scholar]
  12. Cutolo M., Accardo S., Villaggio B., Clerico P., Indiveri F., Carruba G., Fecarotta E., Castagnetta L. Evidence for the presence of androgen receptors in the synovial tissue of rheumatoid arthritis patients and healthy controls. Arthritis Rheum. 1992 Sep;35(9):1007–1015. doi: 10.1002/art.1780350905. [DOI] [PubMed] [Google Scholar]
  13. Cutolo M., Balleari E., Giusti M., Intra E., Accardo S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum. 1991 Jan;34(1):1–5. doi: 10.1002/art.1780340102. [DOI] [PubMed] [Google Scholar]
  14. Cutolo M., Balleari E., Giusti M., Monachesi M., Accardo S. Sex hormone status in women suffering from rheumatoid arthritis. J Rheumatol. 1986 Dec;13(6):1019–1023. [PubMed] [Google Scholar]
  15. Cutolo M., Balleari E., Giusti M., Monachesi M., Accardo S. Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum. 1988 Oct;31(10):1314–1317. doi: 10.1002/art.1780311015. [DOI] [PubMed] [Google Scholar]
  16. Ettinger B., Genant H. K., Cann C. E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985 Mar;102(3):319–324. doi: 10.7326/0003-4819-102-3-319. [DOI] [PubMed] [Google Scholar]
  17. Goemaere S., Ackerman C., Goethals K., De Keyser F., Van der Straeten C., Verbruggen G., Mielants H., Veys E. M. Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol. 1990 Dec;17(12):1620–1622. [PubMed] [Google Scholar]
  18. Grossman C. J., Sholiton L. J., Helmsworth J. A. Characteristics of the cytoplasmic and nuclear dihydrotestosterone receptors of human thymic tissue. Steroids. 1983 Jul;42(1):11–22. doi: 10.1016/s0039-128x(83)90048-x. [DOI] [PubMed] [Google Scholar]
  19. Grossman C. Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesis. J Steroid Biochem. 1989;34(1-6):241–251. doi: 10.1016/0022-4731(89)90088-5. [DOI] [PubMed] [Google Scholar]
  20. Harris E. D., Jr Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 1990 May 3;322(18):1277–1289. doi: 10.1056/NEJM199005033221805. [DOI] [PubMed] [Google Scholar]
  21. Kay C. R., Wingrave S. J. Oral contraceptives and rheumatoid arthritis. Lancet. 1983 Jun 25;1(8339):1437–1437. doi: 10.1016/s0140-6736(83)92378-4. [DOI] [PubMed] [Google Scholar]
  22. Koch A. E., Kunkel S. L., Harlow L. A., Mazarakis D. D., Haines G. K., Burdick M. D., Pope R. M., Strieter R. M. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest. 1994 Mar;93(3):921–928. doi: 10.1172/JCI117097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lahita R. G. Sex steroids and the rheumatic diseases. Arthritis Rheum. 1985 Feb;28(2):121–126. doi: 10.1002/art.1780280202. [DOI] [PubMed] [Google Scholar]
  24. Li Z. G., Danis V. A., Brooks P. M. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol. 1993 Mar-Apr;11(2):157–162. [PubMed] [Google Scholar]
  25. Lindblad S., Wredmark T. Traumatic synovitis analysed by arthroscopy and immunohistopathology. Br J Rheumatol. 1990 Dec;29(6):422–425. doi: 10.1093/rheumatology/29.6.422. [DOI] [PubMed] [Google Scholar]
  26. Masi A. T. Incidence of rheumatoid arthritis: do the observed age-sex interaction patterns support a role of androgenic-anabolic steroid deficiency in its pathogenesis? Br J Rheumatol. 1994 Aug;33(8):697–699. doi: 10.1093/rheumatology/33.8.697. [DOI] [PubMed] [Google Scholar]
  27. Ollier W., Spector T., Silman A., Perry L., Ord J., Thomson W., Festenstein H. Are certain HLA haplotypes responsible for low testosterone levels in males? Dis Markers. 1989 Jul-Sep;7(3):139–143. [PubMed] [Google Scholar]
  28. Polan M. L., Loukides J., Nelson P., Carding S., Diamond M., Walsh A., Bottomly K. Progesterone and estradiol modulate interleukin-1 beta messenger ribonucleic acid levels in cultured human peripheral monocytes. J Clin Endocrinol Metab. 1989 Dec;69(6):1200–1206. doi: 10.1210/jcem-69-6-1200. [DOI] [PubMed] [Google Scholar]
  29. Schuurs A. H., Verheul H. A. Effects of gender and sex steroids on the immune response. J Steroid Biochem. 1990 Feb;35(2):157–172. doi: 10.1016/0022-4731(90)90270-3. [DOI] [PubMed] [Google Scholar]
  30. Sthoeger Z. M., Chiorazzi N., Lahita R. G. Regulation of the immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation. J Immunol. 1988 Jul 1;141(1):91–98. [PubMed] [Google Scholar]
  31. Talal N. Autoimmunity and sex revisited. Clin Immunol Immunopathol. 1989 Dec;53(3):355–357. doi: 10.1016/0090-1229(89)90001-9. [DOI] [PubMed] [Google Scholar]
  32. Tsoukas C. D., Provvedini D. M., Manolagas S. C. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science. 1984 Jun 29;224(4656):1438–1440. doi: 10.1126/science.6427926. [DOI] [PubMed] [Google Scholar]
  33. Zava D. T., McGuire W. L. Androgen action through estrogen receptor in a human breast cancer cell line. Endocrinology. 1978 Aug;103(2):624–631. doi: 10.1210/endo-103-2-624. [DOI] [PubMed] [Google Scholar]
  34. van Vollenhoven R. F., Engleman E. G., McGuire J. L. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum. 1994 Sep;37(9):1305–1310. doi: 10.1002/art.1780370906. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES